J Bone Metab.  2019 Aug;26(3):193-199. 10.11005/jbm.2019.26.3.193.

The Effect of Education and Vitamin D Supplementation on the Achievement of Optimal Vitamin D Level in Korean Postmenopausal Women

Affiliations
  • 1Department of Family Medicine, Chungnam National University Hospital, Daejeon, Korea. fmdr4u@gmail.com
  • 2Department of Family Medicine, College of Medicine, Chungnam National University, Daejeon, Korea.

Abstract

BACKGROUND
Despite daily vitamin D recommendations, women with osteoporosis may not achieve optimal 25-hydroxy-vitamin D (25[OH]D) levels. We retrospectively evaluated the effect of education and vitamin D supplementation (1,000 IU/day) in Korean women with osteoporosis.
METHODS
Sixty-one women with osteoporosis who were taking cholecalciferol (800-1,000 IU/day) were enrolled during 2011 to 2012. Forty patients (education only, Edu group) were educated on the importance of >30 min sunlight exposure daily while taking vitamin D. Twenty-one patients (education with vitamin D supplementation, Add group) were prescribed 1,000 IU/day cholecalciferol (total 1,800-2,000 IU/day) plus education. Patients were divided into 3 groups according to serum 25(OH)D status: deficiency (<20 ng/mL), insufficiency (20-30 ng/mL), and sufficiency (≥30 ng/mL). Furthermore, 25(OH)D levels were compared at baseline and after intervention for 3 months.
RESULTS
The median (interquartile range) serum 25(OH)D concentration at baseline was 25.10 (18.95-33.60) ng/mL. The mean (±standard error) differences in 25(OH)D levels from baseline to post-intervention were 19.85±3.86 and 31.73±4.82 ng/mL in the Edu group and Add group, respectively. Eighteen patients (29.5%) had vitamin D deficiency, 25 (41.0%) had insufficiency, and 18 (29.5%) had sufficient levels. Optimal 25(OH)D (30 ng/mL or more) was achieved in 54.5% and 95.2% patients in the Edu group and Add group, respectively (P=0.003).
CONCLUSIONS
We consider that vitamin D concentration should be measured on a regular basis in order to maintain an optimal level of vitamin D concentration, and education and supplementation is needed if not sufficient.

Keyword

Cholecalciferol; Osteoporosis; Postmenopause; Vitamin D

MeSH Terms

Cholecalciferol
Education*
Female
Humans
Osteoporosis
Postmenopause
Retrospective Studies
Sunlight
Vitamin D Deficiency
Vitamin D*
Vitamins*
Cholecalciferol
Vitamin D
Vitamins

Reference

1. Holick MF. Vitamin D deficiency. N Engl J Med. 2007; 357:266–281.
Article
2. Parfitt AM. Osteomalacia and related disorders. In : Avioli LV, Krane SM, editors. Metabolic bone disease and clinically related disorders. 2nd ed. Philadelphia, PA: W.B. Saunders Company;1990. p. 329–396.
3. Sahota O, Masud T, San P, et al. Vitamin D insufficiency increases bone turnover markers and enhances bone loss at the hip in patients with established vertebral osteoporosis. Clin Endocrinol (Oxf). 1999; 51:217–221.
Article
4. Malavolta N, Pratelli L, Frigato M, et al. The relationship of vitamin D status to bone mineral density in an Italian population of postmenopausal women. Osteoporos Int. 2005; 16:1691–1697.
Article
5. Kim KM, Choi HS, Choi MJ, et al. Calcium and vitamin D supplementations: 2015 position statement of the Korean society for bone and mineral research. J Bone Metab. 2015; 22:143–149.
Article
6. Dawson-Hughes B, Heaney RP, Holick MF, et al. Estimates of optimal vitamin D status. Osteoporos Int. 2005; 16:713–716.
Article
7. Choi EY. 25(OH)D status and demographic and lifestyle determinants of 25(OH)D among Korean adults. Asia Pac J Clin Nutr. 2012; 21:526–535.
8. Kim JJ, Kim SS, Yoon SJ, et al. Vitamin d status and response to initial vitamin d supplementation in Korean women with osteoporosis. J Bone Metab. 2014; 21:257–262.
Article
9. Cannell JJ, Hollis BW. Use of vitamin D in clinical practice. Altern Med Rev. 2008; 13:6–20.
10. Leidig-Bruckner G, Roth HJ, Bruckner T, et al. Are commonly recommended dosages for vitamin D supplementation too low? Vitamin D status and effects of supplementation on serum 25-hydroxyvitamin D levels--an observational study during clinical practice conditions. Osteoporos Int. 2011; 22:231–240.
Article
11. Bischoff-Ferrari HA, Shao A, Dawson-Hughes B, et al. Benefit-risk assessment of vitamin D supplementation. Osteoporos Int. 2010; 21:1121–1132.
Article
12. Ryu OH, Lee S, Yu J, et al. A prospective randomized controlled trial of the effects of vitamin D supplementation on long-term glycemic control in type 2 diabetes mellitus of Korea. Endocr J. 2014; 61:167–176.
Article
13. Ryu OH, Chung W, Lee S, et al. The effect of high-dose vitamin D supplementation on insulin resistance and arterial stiffness in patients with type 2 diabetes. Korean J Intern Med. 2014; 29:620–629.
Article
14. Ivorra J, Valls E, Fernández-Llanio Comella N, et al. Vitamin D status in osteoporotic postmenopausal women taking oral recommended vitamin D supplementation. Med Clin (Barc). 2012; 138:199–201.
15. Gallagher JC, Sai A, Templin T 2nd, et al. Dose response to vitamin D supplementation in postmenopausal women: a randomized trial. Ann Intern Med. 2012; 156:425–437.
Article
Full Text Links
  • JBM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr